ARTICLE | Clinical News
Erbitux cetuximab regulatory update
June 27, 2005 7:00 AM UTC
The partners plan to submit in the third quarter an sBLA to FDA for Erbitux cetuximab in combination with radiation to treat squamous cell carcinoma of the head and neck (SCCHN). Earlier this year, th...